Related Experiment Videos
Mouse model for Burkitt's lymphoma will aid understanding and therapy
1Department of Science, St Louis University, Madrid campus, Spain
Drug Discovery Today
|February 13, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The PROTAC milestone: FDA approval of vepdegestrant (ARV-471) for ESR1-mutated breast cancer.
Drug discovery today·2026
Model Gateway: Management platform for model-driven drug discovery.
Drug discovery today·2026
Small nucleolar RNAs: Emerging therapeutic and diagnostic frontiers in Alzheimer's disease.
Drug discovery today·2026
Outer membrane as a drug target for the treatment of GNB infections.
Drug discovery today·2026
From structural biology to precision medicine-decoding the key receptor in thyroid disorders.
Drug discovery today·2026
The Diagnostic Performance of Afirma Genomic Sequencing Classifier in Black and Hispanic Patients With Indeterminate Thyroid Nodules.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
A tumor-on-a-chip model reveals and targets reciprocal macrophage-NK cell crosstalk to advance immunotherapy screening.
Microsystems & nanoengineering·2026
Successful Non-surgical Treatment for a Duodenal Perforation Caused by the Rupture of an Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Internal medicine (Tokyo, Japan)·2026
Predictors of immunotherapy response in gastric cancer: the role of the tumor microenvironment and integrative predictive models.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
ICOS-ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026